A One‐Strength Dose Escalation Regimen for Birch Pollen Subcutaneous Immunotherapy Is Safe and Tolerable in Children, Adolescents, and Adults

Marek Jutel, Ludger Klimek, Michael Gerstlauer, Dana Troyke, Kristina Duwensee, Christian Vogelberg

Open source

DOI
10.1111/all.70265
Published
2026-02-23
Container
Allergy
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/all.70265,
  title = {A One‐Strength Dose Escalation Regimen for Birch Pollen Subcutaneous Immunotherapy Is Safe and Tolerable in Children, Adolescents, and Adults},
  author = {Marek Jutel and Ludger Klimek and Michael Gerstlauer and Dana Troyke and Kristina Duwensee and Christian Vogelberg},
  year = {2026},
  journal = {Allergy},
  doi = {10.1111/all.70265},
  url = {https://doi.org/10.1111/all.70265}
}

RIS

TY  - JOUR
TI  - A One‐Strength Dose Escalation Regimen for Birch Pollen Subcutaneous Immunotherapy Is Safe and Tolerable in Children, Adolescents, and Adults
AU  - Marek Jutel
AU  - Ludger Klimek
AU  - Michael Gerstlauer
AU  - Dana Troyke
AU  - Kristina Duwensee
AU  - Christian Vogelberg
PY  - 2026
JO  - Allergy
DO  - 10.1111/all.70265
UR  - https://doi.org/10.1111/all.70265
ER  - 

APA

Jutel, M., Klimek, L., Gerstlauer, M., Troyke, D., Duwensee, K., & Vogelberg, C. (2026). A One‐Strength Dose Escalation Regimen for Birch Pollen Subcutaneous Immunotherapy Is Safe and Tolerable in Children, Adolescents, and Adults. Allergy. https://doi.org/10.1111/all.70265

Source records